Metastatic triple-negative breast cancer successfully treated with bicalutamide
Triple-negative breast cancer (TNBC) is considered the group with the worst prognosis among the four molecular subtypes of breast cancer. The current treatment of metastatic TNBC is traditionally limited to chemotherapy. Androgenic receptors (AR) are an emerging target with therapeutic potential in...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
African Field Epidemiology Network
2020
|
| Online Access: | http://eprints.uanl.mx/29984/7/29984.pdf |